OTLK (Outlook Therapeutics, Inc. Common Stock)
Insider Trading Activity
Every open-market purchase and sale reported by OTLK officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-02 | Kevin Michael Lundquist | Chief Financial Officer | A | — | — |
| 2026-08-14 | LAWRENCE A KENYON | Chief Financial Officer | Buy | — | — |
| 2026-08-14 | Robert Charles Jahr | Chief Executive Officer | Buy | — | — |
| 2026-08-14 | Ghiath M. Sukhtian | Director | Buy | — | — |
| 2026-07-29 | Faisal Ghiath Sukhtian | Director | Buy | — | — |
| 2026-07-23 | Robert Charles Jahr | Chief Executive Officer | A | — | — |
| 2026-07-23 | LAWRENCE A KENYON | Chief Financial Officer | A | — | — |
| 2026-06-03 | Yezan Munther Haddadin | Director | Buy | — | — |
| 2026-06-01 | GMS Ventures & Investments | Director | Buy | — | — |
| 2026-05-27 | RANDY H THURMAN | Director | Buy | — | — |
| 2026-05-27 | Yezan Munther Haddadin | Director | Buy | — | — |
| 2026-05-27 | Faisal Ghiath Sukhtian | Director | Buy | — | — |
| 2026-05-27 | KURT J HILZINGER | Director | Buy | — | — |
| 2025-10-03 | Julian S Gangolli | Director | A | — | — |
| 2025-10-03 | Andong Huang | Director | A | — | — |
| 2025-10-03 | Gerd Auffarth | Director | A | — | — |
| 2025-10-03 | Faisal Ghiath Sukhtian | Director | A | — | — |
| 2025-10-03 | Julia A Haller | Director | A | — | — |
| 2025-10-03 | KURT J HILZINGER | Director | A | — | — |
| 2025-10-03 | RANDY H THURMAN | Director | A | — | — |
| 2025-10-03 | Yezan Munther Haddadin | Director | A | — | — |
| 2025-07-09 | Robert Charles Jahr | Chief Executive Officer | A | — | — |
| 2025-05-28 | Ghiath M. Sukhtian | Director | A | — | — |
| 2025-03-12 | GMS Ventures & Investments | Director | M | — | — |
| 2025-02-06 | Faisal Ghiath Sukhtian | Director | A | — | — |
| 2025-01-22 | GMS Ventures & Investments | Director | MIXED | — | — |
| 2024-10-03 | Faisal Ghiath Sukhtian | Director | A | — | — |
| 2024-10-03 | Andong Huang | Director | A | — | — |
| 2024-10-03 | Gerd Auffarth | Director | A | — | — |
| 2024-10-03 | Julia A Haller | Director | A | — | — |
| 2024-10-03 | KURT J HILZINGER | Director | A | — | — |
| 2024-10-03 | Yezan Munther Haddadin | Director | A | — | — |
| 2024-10-03 | Julian S Gangolli | Director | A | — | — |
| 2024-10-03 | RANDY H THURMAN | Director | A | — | — |
| 2024-09-30 | LAWRENCE A KENYON | Chief Financial Officer | Buy | — | — |
| 2024-04-17 | Syntone Ventures LLC | 10%+ Owner | Buy | — | — |
| 2024-03-29 | Yezan Munther Haddadin | Director | Buy | — | — |
| 2024-03-22 | C RUSSELL TRENARY III | CEO AND PRESIDENT | A | — | — |
| 2024-03-22 | Jeff Evanson | CHIEF COMMERCIAL OFFICER | A | — | — |
| 2024-03-22 | LAWRENCE A KENYON | CHIEF FINANCIAL OFFICER | A | — | — |
| 2024-03-20 | GMS Ventures & Investments | Director | A | — | — |
| 2024-03-11 | Jeff Evanson | CHIEF COMMERCIAL OFFICER | Buy | — | — |
| 2024-03-08 | Faisal Ghiath Sukhtian | Director | A | — | — |
| 2024-03-08 | RANDY H THURMAN | Director | A | — | — |
| 2024-03-08 | Gerd Auffarth | Director | A | — | — |
| 2024-03-08 | Andong Huang | Director | A | — | — |
| 2024-03-08 | Julia A Haller | Director | A | — | — |
| 2024-03-08 | KURT J HILZINGER | Director | A | — | — |
| 2024-03-08 | Julian S Gangolli | Director | A | — | — |
| 2024-03-08 | Yezan Munther Haddadin | Director | A | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | Director | 24,617,320 | — |
| — | Director | 22,092,068 | — |
| — | 10%+ Owner | 1,705,438 | — |
| — | 10%+ Owner | 1,149,126 | — |
| — | Director | 423,655 | — |
| — | Director | 220,972 | — |
| — | Chief Executive Officer | 151,515 | — |
| — | Chief Financial Officer | 106,956 | — |
| — | Director | 66,167 | — |
| — | CHIEF COMMERCIAL OFFICER | 40,423 | — |
| — | Chief Operations Officer | 32,653 | — |
| — | Director | 5,593 | — |
| — | CEO AND PRESIDENT | 2,746 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the OTLK quote page; the site-wide leaderboard is on the insider transactions hub.